Cholesterol and COVID19 lethality in elderly
A new study published on the preprint server bioRxiv* in May 2020 suggests that the strikingly increased mortality in COVID-19 patients who
Tag: Covid-19
Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and Covid-19
Coronavirus is a family of viruses that cause respiratory infections.The new coronavirus agent was discovered on 12/31/19 after cases registered
Voluntary Licensing Agreements for Remdesivir
Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand
Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
Japan approved the Gilead Sciences antiviral drug remdesivir Thursday for treatment of severe COVID-19 patients, under an exceptional approval pathway
UC Berkeley, Excivion and CycloLab develop antiviral cyclodextrins against SARS-CoV-2
UC Berkeley, Excivion and Cyclolab announce a supplemental grant awarded to UC Berkeley by the National Institutes of Health to evaluate a wide
Gilead outlines plans to distribute COVID-19 drug worldwide
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
SBECD-enabled Remdesivir Receives FDA’s Emergency Use Authorization for the Treatment of COVID-19
Gilead Sciences, Inc. yesterday announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for
Gilead’s Remdesivir meets main goal of trial in COVID-19 patients
Gilead Sciences today announced that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with
Like soap for the patient’s mouth—cyclodextrins are important for future of oral care
Dental Tribune, the European blog of dentists published a post on the possible application of cyclodextrins as a mouth rinse
Japan to approve remdesivir for coronavirus patients in May
Prime Minister Shinzo Abe said Monday that Japan will soon approve the SBECD-eanbled anti-viral drug remdesivir for the treatment of